Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis - Wikidata - wikimedia - TriplyDB

Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis

Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis

http://www.wikidata.org/entity/Q28480576

about

Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis GenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates Performance of the MTBDRsl assay in Georgia.Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study.Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh.Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.Macronutrient intake and body composition changes during anti-tuberculosis therapy in adults.A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.A culture-specific nutrient intake assessment instrument in patients with pulmonary tuberculosis.Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis.Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco.Diagnostic usefulness of the GenoType MTBDRplus assay for detecting drug-resistant tuberculosis using AFB smear-negative specimens with positive TB-PCR result.Recommendations for the diagnosis of pediatric tuberculosis.Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil.Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.

P2860

Q28536857-BD6FE44F-8C04-4705-B596-1DFE19E84E03 Q28537807-9CE7F130-0040-4C47-A92A-B256D94186CF Q28550477-A14DD83E-6D00-46D9-9B4C-E9D6B8A86444 Q30835490-73E674D6-B552-498B-86D1-74267191AE02 Q33668222-034125ED-2565-4BBE-828C-A46B86099085 Q34137755-EF80BDE2-D1DE-4CC1-9A23-5451C9AFEAC8 Q34343488-C2786AF8-D553-40DA-ADCD-95504F075F47 Q35107029-E99D2C49-E134-4647-A091-1D6B25C597C1 Q35149068-88114F2D-B659-40DC-8808-88FF9CEE6047 Q35171825-D1D28448-3B87-40BD-B369-570C6534F1B7 Q35607890-1474D096-1DA1-4A46-8994-E2FB2704EEDB Q35670115-D624C58C-0762-4ACA-9C36-22B3735609FB Q35673445-BE84605C-98EE-4B4E-B1FF-2FBD404C83AC Q35822104-6D8E06F8-8B6B-4F19-9A43-5D1D88A7D16D Q35843178-9DE50E1D-712C-4CC1-A011-56F768FCEA13 Q35909558-3C19A211-A2D5-4040-B28E-ABAFF709AB6A Q35990631-DCED528E-6845-4A09-9347-92285E156A45 Q35998486-D6F1798D-DEC5-407F-9D26-B7382FE9FEAD Q36035420-080DB6EB-E69F-4D60-862E-F3FC55EB2DD9 Q36035954-9D179A83-97AA-4D04-AB86-DCC238F2948B Q36223038-B4C3CAD2-4A9D-4905-9F66-496CAE556F89 Q36855346-5BF0003A-F876-4874-B836-DB2EC04C003B Q36997317-1136DA4B-C591-43CC-B184-FB7046640C48 Q37058582-87B9FC34-AE2D-4D26-B747-6ABBE07316A8 Q37204743-87B2D911-336B-40C1-8F4A-9A5608E35160 Q37419643-4DB143E9-E504-45A4-BCED-6BD29CAE8D60 Q38419738-C7D1A23B-4DB5-4F95-9FC8-A7F4A992C864 Q38609947-140B67D8-0EBE-4EBB-B81D-48199E43C4AC Q38623426-A5812B79-694E-4C1D-9636-40C36412BE60 Q38718388-D3FB58E1-73C9-4FAF-BA6F-933B2D8784F1 Q39094119-26D1B406-C8B0-4C7A-83CC-DD1BB8AB226A Q40260172-EF009CC8-A177-4AAC-9711-59868AE79499

P2860

Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis

http://www.wikidata.org/entity/Q28480576

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@ast

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@en

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@nl

type

label

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@ast

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@en

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@nl

prefLabel

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@ast

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@en

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@nl

P1433

Q28480576-FA09DF64-FF8A-48C0-A488-549E32984868

P1476

Q28480576-453EBD5C-B953-42A8-9E7A-AF6CBB485C5F

P2093

Q28480576-1AE1B0EB-9A95-49B3-A2FA-319FB516F05E

Q28480576-39364D0C-4DB5-4810-A6BB-B660A5611136

Q28480576-57228C77-E6F2-487F-991B-5438F8BD4B2D

Q28480576-7DD361A7-2B80-4716-82F2-D0C1026E333A

Q28480576-C4BB6315-5C7F-4ECD-B658-652D801D4B02

Q28480576-C8B09BB9-9153-4915-A65E-5468D7006169

Q28480576-CA40253C-8E80-494F-A380-18874E837E66

Q28480576-E8EDC6A4-E92B-4CF5-B361-FA71FEF7F1D2

Q28480576-F5EA0142-8528-4082-8959-9785B6599357

P2860

Q28480576-00C8163E-EAAD-48C5-9A6E-827E18C658DB

Q28480576-0D90F0D5-4A23-4452-A266-DDE4BA37588E

Q28480576-19D9B285-C090-42C5-98BB-91EBA39A8E80

Q28480576-253EB8A6-7263-4D8D-8B06-667FB86440BD

Q28480576-383E0C7F-BF7C-4591-AC0D-93EB3E8D23A0

Q28480576-4FB7D1E5-BCF0-4E6E-89B3-EBB785B7B9DC

Q28480576-6C7D7295-226A-4FD0-AC34-B7FB01D2A098

Q28480576-71B3B630-807A-4F67-AF1C-8C193AEA66D9

Q28480576-782F7661-CCD0-475E-B870-854A518EE335

Q28480576-85328FCE-15AB-46F0-9F39-0C61ED439EB7

P304

Q28480576-9B57B44E-7186-4316-B628-FA0CC03D9743

P31

Q28480576-78BCA3CE-0D5C-4290-BF8D-CFB29CAB4C64

P356

Q28480576-9982BA95-9B73-4437-83D8-6DD350ACC45F

P407

Q28480576-4BFC4770-8B73-4468-8DB1-706C937F491D

P433

Q28480576-BD613EF5-0B97-4FBF-98A5-8B46908F5082

P478

Q28480576-10DB71B4-ACD2-47C1-A773-BACACFD7FC2F

P577

Q28480576-05B3B3F6-C94F-4898-A2D8-C1DE768F662D

P5875

Q28480576-192998F6-527F-4937-8006-E61375CC44D5

P698

Q28480576-14D1946B-CC00-4CE0-88F0-C9B954199686

P921

Q28480576-0F691DD6-00AC-41DC-A227-A33FF926A4AD

Q28480576-389A16F5-B18B-448C-99FE-7C2CC48D8875

Q28480576-3b29462f-6bdc-494a-adf5-eda772a78e2d

P932

Q28480576-867B9008-1FF7-4AB7-81DB-2D75E1CAACA2

P356

JOURNAL.PONE.0031563

P1433

P1476

Use of a molecular diagnostic ...... ltidrug resistant tuberculosis

@en

P2093

Ekaterina Kurbatova

http://www.w3.org/2001/XMLSchema#string

Henry M Blumberg

http://www.w3.org/2001/XMLSchema#string

Iagor Kalandadze

http://www.w3.org/2001/XMLSchema#string

Maia Kipiani

http://www.w3.org/2001/XMLSchema#string

Michael K Leonard

http://www.w3.org/2001/XMLSchema#string

Nestani Tukvadze

http://www.w3.org/2001/XMLSchema#string

Nino Bablishvili

http://www.w3.org/2001/XMLSchema#string

Russell R Kempker

http://www.w3.org/2001/XMLSchema#string

Rusudan Apsindzelashvili

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis.

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.

P304

e31563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0031563

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221844897

http://www.w3.org/2001/XMLSchema#string

P698

22347495

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

3276512

http://www.w3.org/2001/XMLSchema#string